Related Experiment Videos
Molecular cytogenetics: diagnosis and prognostic assessment
J W Gray1, A Kallioniemi, O Kallioniemi
1Department of Laboratory Medicine, University of California, San Francisco 94143-0808.
Current Opinion in Biotechnology
|December 1, 1992
Summary
This review covers molecular cytogenetic methods like fluorescence in situ hybridization for identifying genetic changes in human diseases. These techniques aid in diagnosing conditions before and after birth and characterizing cancers.
Area of Science:
- Molecular Cytogenetics
- Human Genetics
- Medical Diagnostics
Background:
- Genetic aberrations are linked to numerous human diseases.
- Accurate detection and characterization of these aberrations are crucial for diagnosis and treatment.
- Traditional cytogenetic methods have limitations in resolution and scope.
Purpose of the Study:
- To review advanced molecular cytogenetic techniques for detecting and characterizing genetic aberrations.
- To discuss the principles and applications of fluorescence in situ hybridization (FISH), primed in situ labeling (PRINS), and comparative genome hybridization (CGH).
- To highlight the utility of these methods in prenatal diagnosis, neonatal screening, and cancer characterization.
Main Methods:
- Fluorescence in situ hybridization (FISH)
- Primed in situ labeling (PRINS)
- Comparative genome hybridization (CGH)
- Use of probes for repetitive sequences, whole chromosomes, and specific loci.
Main Results:
- Detailed description of FISH, PRINS, and CGH methodologies.
- Explanation of probe types for various genetic targets.
- Demonstration of the application of these techniques in clinical settings.
Conclusions:
- Molecular cytogenetic techniques offer powerful tools for precise detection and characterization of genetic abnormalities.
- These methods significantly advance prenatal/neonatal diagnostics and the understanding of human malignancies.
- Continued development and application of these technologies will improve patient outcomes.